Soleus Private Equity Amends NeuroPace Stake (SC 13G/A)

TL;DR

**Soleus Private Equity updated its NeuroPace stake, watch for market reaction.**

AI Summary

Soleus Private Equity Fund I, L.P. filed an Amendment No. 3 to Schedule 13G on February 2, 2024, indicating a change in their ownership of NeuroPace Inc. (CUSIP 641288105) as of December 31, 2023. This filing, under Rule 13d-1(c), updates their previously disclosed stake in the medical device company. This matters to investors because significant changes in institutional ownership can signal shifts in confidence or strategy regarding the stock, potentially influencing its future price movements.

Why It Matters

Changes in major institutional holdings can impact investor sentiment and stock liquidity, signaling a potential re-evaluation of NeuroPace Inc.'s prospects by a sophisticated investor.

Risk Assessment

Risk Level: low — This filing is a routine update of ownership, not indicating any immediate negative or positive event for the company.

Analyst Insight

Investors should monitor subsequent filings from Soleus Private Equity Fund I, L.P. to understand the magnitude of any change in their NeuroPace Inc. holdings and consider if other institutional investors are making similar moves.

Key Players & Entities

• Soleus Private Equity Fund I, L.P. (company) — the reporting person filing the SC 13G/A
• NeuroPace Inc. (company) — the subject company whose shares are being reported
• December 31, 2023 (date) — the date of the event requiring the filing
• February 2, 2024 (date) — the filing date of the SC 13G/A
• 641288105 (other) — the CUSIP number for NeuroPace Inc. Common Stock

FAQ

Filing Documents

• ea192408-13ga3soleus1_neuro.htm (SC 13G/A) — 158KB
• 0001213900-24-009346.txt ( ) — 160KB

Ownership of Five Percent or Less of a Class

Item 5. Ownership of Five Percent or Less of a Class Not applicable.

Ownership of More than Five Percent on Behalf of Another

Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable.

Identification and Classification of the Subsidiary Which

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company Not applicable.

Identification and Classification of Members of the Group

Item 8. Identification and Classification of Members of the Group Not applicable.

Notice of Dissolution of Group

Item 9. Notice of Dissolution of Group Not applicable.

Certification

Item 10. Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose, or with the effect, of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. 11 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct. Date : February 2, 2024 Soleus Private Equity Fund I, L.P. By: Soleus Private Equity GP I, LLC, its General Partner By: Soleus PE GP I, LLC, its Manager By: /s/ Guy Levy Name: Guy Levy Title: Managing Member Date : February 2, 2024 Soleus Private Equity GP I, LLC By: Soleus PE GP I, LLC, its Manager By: /s/ Guy Levy Name: Guy Levy Title: Managing Member Date : February 2, 2024 Soleus PE GP I, LLC By: /s/ Guy Levy Name: Guy Levy Title: Managing Member Date : February 2, 2024 Soleus Capital Master Fund, L.P. By: Soleus Capital, LLC, its General Partner By: Soleus Capital Group, LLC, its Managing Manager By: /s/ Guy Levy Name: Guy Levy Title: Managing Member 12 Date : February 2, 2024 Soleus Capital, LLC By: Soleus Capital Group, LLC, its Managing Manager By: /s/ Guy Levy Name: Guy Levy Title: Managing Member Date : February 2, 2024 Soleus Capital Group, LLC By: /s/ Guy Levy Name: Guy Levy Title: Managing Member Date : February 2, 2024 /s/ Guy Levy Name: Guy Levy Footnotes: Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001) 13

View Full Filing

View this SC 13G/A filing on SEC EDGAR